Boostrix-IPV suspension for injection 0.5ml pre-filled syringes United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

boostrix-ipv suspension for injection 0.5ml pre-filled syringes

glaxosmithkline uk ltd - tetanus toxoid; pertussis antigens; human poliovirus type 1 inactivated; human poliovirus type 2 inactivated; human poliovirus type 3 inactivated; diphtheria toxoid - suspension for injection

Repevax vaccine suspension for injection 0.5ml pre-filled syringes United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

repevax vaccine suspension for injection 0.5ml pre-filled syringes

sanofi - tetanus toxoid; pertussis antigens; human poliovirus type 1 inactivated; human poliovirus type 2 inactivated; human poliovirus type 3 inactivated; diphtheria toxoid - suspension for injection

Pediacel vaccine suspension for injection 0.5ml vials United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

pediacel vaccine suspension for injection 0.5ml vials

sanofi pasteur msd ltd - human poliovirus type 3 inactivated; tetanus toxoid; pertussis antigens; human poliovirus type 1 inactivated; human poliovirus type 2 inactivated; diphtheria toxoid; haemophilus influenzae type b polysaccharide protein conjugate - suspension for injection

Infanrix-IPV vaccine suspension for injection 0.5ml pre-filled syringes United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

infanrix-ipv vaccine suspension for injection 0.5ml pre-filled syringes

glaxosmithkline uk ltd - diphtheria toxoid; tetanus toxoid; pertussis antigens; human poliovirus type 1 inactivated; human poliovirus type 2 inactivated; human poliovirus type 3 inactivated - suspension for injection

Infanrix-IPV + Hib vaccine powder and suspension for suspension for injection 0.5ml pre-filled syringes United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

infanrix-ipv + hib vaccine powder and suspension for suspension for injection 0.5ml pre-filled syringes

glaxosmithkline uk ltd - diphtheria toxoid; tetanus toxoid; pertussis antigens; human poliovirus type 1 inactivated; human poliovirus type 2 inactivated; human poliovirus type 3 inactivated; haemophilus influenzae type b polysaccharide protein conjugate - powder and suspension for suspension for injection

Infanrix Hexa vaccine powder and suspension for suspension for injection 0.5ml pre-filled syringes United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

infanrix hexa vaccine powder and suspension for suspension for injection 0.5ml pre-filled syringes

glaxosmithkline uk ltd - tetanus toxoid; pertussis antigens; human poliovirus type 3 inactivated; human poliovirus type 2 inactivated; human poliovirus type 1 inactivated; hepatitis b virus surface antigen; haemophilus influenzae type b polysaccharide protein conjugate; diphtheria toxoid - powder and suspension for suspension for injection

Repevax vaccine suspension for injection 0.5ml pre-filled syringes United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

repevax vaccine suspension for injection 0.5ml pre-filled syringes

sanofi pasteur msd ltd - diphtheria toxoid; tetanus toxoid; pertussis antigens; human poliovirus type 1 inactivated; human poliovirus type 2 inactivated; human poliovirus type 3 inactivated - suspension for injection

CSL TETANUS IMMUNOGLOBULIN VF (human) 250IU injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

csl tetanus immunoglobulin vf (human) 250iu injection vial

csl behring australia pty ltd - tetanus immunoglobulin, quantity: 250 iu; human immunoglobulin g, quantity: 160 mg/ml - injection, solution - excipient ingredients: glycine; human immunoglobulin a - tetanus immunoglobulin is indicated for the passive protection of individuals who have sustained a tetanus-prone wound and who have either not been actively immunised against tetanus or whose immunisation history is doubtful. it should also be given to the fully immunised patient with a tetanus-prone wound if more than 10 years have elapsed since the last dose of toxoid. in all the above instances, active immunisation with tetanus toxoid, adsorbed or adt vaccine should be commenced at the same time [in accordance with details specified in table 1 (guide to tetanus prophylaxis in wound management) in indication section of the approved product information provided as attachment 1]. although tetanus immunoglobulin and vaccine should be given at the same time, they should be administered in opposite limbs, using separate syringes.

Tetanus Immunoglobulin-VF New Zealand - English - Medsafe (Medicines Safety Authority)

tetanus immunoglobulin-vf

csl behring (nz) ltd - tetanus immunoglobulin, human 250 [iu] (immunoglobulin ex nz =160mg/ml) - solution for injection - 250 iu - active: tetanus immunoglobulin, human 250 [iu] (immunoglobulin ex nz =160mg/ml) excipient: glycine - tetanus immunoglobulin-vf is indicated for the passive protection of individuals who have sustained a tetanus-prone wound and who have either not been actively immunised against tetanus or whose immunisation history is doubtful. it should also be given to the fully immunised patient with a tetanus-prone wound if more than 10 years have elapsed since the last vaccine dose. in all the above instances, active immunisation with a tetanus vaccine should be commenced at the same time according to current datasheet recommendations.

Human Tetanus Immunoglobulin Malta - English - Medicines Authority

human tetanus immunoglobulin

bio products laboratory limited dagger lane, elstree hertfordshire, wd6 3bx, united kingdom - inactivated strain, flury lep - solution for injection - inactivated strain flury lep 100 iu/ml - immune sera and immunoglobulins